Wang P - Search Results

1

YAP K236 acetylation facilitates its nucleic export and deprived the protection against cardiac hypertrophy in mice.

Wang P, Wang L, Liu C, Hu Y, Feng G, Lian Z, Lu J, He P, Cai H, Liang X, Liu P, Wu X. Wang P, et al. Among authors: wang l. Pharmacol Res. 2025 Jan;211:107573. doi: 10.1016/j.phrs.2024.107573. Epub 2024 Dec 31. Pharmacol Res. 2025. PMID: 39746498 Free article.

2

PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy.

Wang L, Li Z, Tan Y, Li Q, Yang H, Wang P, Lu J, Liu P. Wang L, et al. Among authors: wang p. Mol Cell Endocrinol. 2018 Oct 15;474:137-150. doi: 10.1016/j.mce.2018.02.020. Epub 2018 Mar 1. Mol Cell Endocrinol. 2018. PMID: 29501586

3

PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.

Li Q, Li ZM, Sun SY, Wang LP, Wang PX, Guo Z, Yang HW, Ye JT, Lu J, Liu PQ. Li Q, et al. Acta Pharmacol Sin. 2019 May;40(5):589-598. doi: 10.1038/s41401-018-0044-4. Epub 2018 Jul 20. Acta Pharmacol Sin. 2019. PMID: 30030529 Free PMC article.

4

Sirtuin 1 represses PKC-ζ activity through regulating interplay of acetylation and phosphorylation in cardiac hypertrophy.

Li J, Huang J, Lu J, Guo Z, Li Z, Gao H, Wang P, Luo W, Cai S, Hu Y, Guo K, Wang L, Li Z, Wang M, Zhang X, Liu P. Li J, et al. Among authors: wang l, wang p, wang m. Br J Pharmacol. 2019 Feb;176(3):416-435. doi: 10.1111/bph.14538. Epub 2018 Dec 9. Br J Pharmacol. 2019. PMID: 30414383 Free PMC article.

5

Histone H4R3 symmetric di-methylation by Prmt5 protects against cardiac hypertrophy via regulation of Filip1L/β-catenin.

Cai S, Wang P, Xie T, Li Z, Li J, Lan R, Ding Y, Lu J, Ye J, Wang J, Li Z, Liu P. Cai S, et al. Among authors: wang j, wang p. Pharmacol Res. 2020 Nov;161:105104. doi: 10.1016/j.phrs.2020.105104. Epub 2020 Jul 31. Pharmacol Res. 2020. PMID: 32739429

6

MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.

Ding YQ, Zhang YH, Lu J, Li B, Yu WJ, Yue ZB, Hu YH, Wang PX, Li JY, Cai SD, Ye JT, Liu PQ. Ding YQ, et al. Acta Pharmacol Sin. 2021 Sep;42(9):1422-1436. doi: 10.1038/s41401-020-00563-7. Epub 2020 Nov 27. Acta Pharmacol Sin. 2021. PMID: 33247214 Free PMC article.

7

Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression.

Wang P, Wang M, Hu Y, Chen J, Cao Y, Liu C, Wu Z, Shen J, Lu J, Liu P. Wang P, et al. Among authors: wang m. Acta Pharm Sin B. 2021 Mar;11(3):680-693. doi: 10.1016/j.apsb.2020.10.017. Epub 2020 Nov 1. Acta Pharm Sin B. 2021. PMID: 33777675 Free PMC article.

8

SZC-6, a small-molecule activator of SIRT3, attenuates cardiac hypertrophy in mice.

Li ZY, Lu GQ, Lu J, Wang PX, Zhang XL, Zou Y, Liu PQ. Li ZY, et al. Acta Pharmacol Sin. 2023 Mar;44(3):546-560. doi: 10.1038/s41401-022-00966-8. Epub 2022 Aug 30. Acta Pharmacol Sin. 2023. PMID: 36042291 Free PMC article.

9

Cryptotanshinone attenuates LPS-induced acute lung injury by regulating metabolic reprogramming of macrophage.

Ye Z, Wang P, Feng G, Wang Q, Liu C, Lu J, Chen J, Liu P. Ye Z, et al. Among authors: wang p, wang q. Front Med (Lausanne). 2023 Jan 13;9:1075465. doi: 10.3389/fmed.2022.1075465. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36714100 Free PMC article.

10

SNX3 mediates heart failure by interacting with HMGB1 and subsequently facilitating its nuclear-cytoplasmic translocation.

Li H, Peng MX, Yang RX, Chen JX, Wang YM, Wang PX, Hu YH, Pan DY, Liu PQ, Lu J. Li H, et al. Acta Pharmacol Sin. 2025 Jan 3. doi: 10.1038/s41401-024-01436-z. Online ahead of print. Acta Pharmacol Sin. 2025. PMID: 39753981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43,243 results

Search Page

Filters